Supplies of a bladder cancer drug are dwindling, as patients scramble

Supplies of a bladder cancer drug are dwindling, as patients scramble

With one manufacturer and little money to be made, supplies of a critical cancer drug are dwindling

By MEGHANA KESHAVAN

HYACINTH EMPINADO/STAT

Companies have little incentive to make a drug like BCG, which is remarkably effective at treating bladder cancer but hardly lucrative.

READ MORE